DySIS is the first medical device to use dynamic spectral imaging technology to support clinicians in the detection and mapping of cervical neoplasia in vivo. DySIS delivers the new standard of care in colposcopy. Read more on the product
DySIS employs a unique approach called dynamic spectral imaging to assist clinicians assess the cervix... Read more on the science
See the DySIS clinical data conducted in the EU... Read more on clinical evidence
See DySIS case examples of magnification with overview, aceto-mapping and biopsy guidance and sampling... Read more on clinical cases
DySISmedical is a medical device company that designs, develops, manufactures and markets imaging systems that facilitate the non-invasive, in-vivo detection of cancerous and pre-cancerous lesions. DySISmedical assists medical practitioners to improve patient care by incorporating advanced biophotonics and optical molecular imaging technologies that assist in early detection, diagnosis and monitoring.
- 30 January 2012
- DySIS Medical Appoints New Chairman
- 13 January 2012
- DySIS Launched in France
- 24 October 2011
- Raising the awareness of DySIS in Sweden